Abstract
1. Fenclozic acid (2-(4-chlorophenyl)thiazol-4-ylacetic acid; I.C.I. 54,450; “Myalex”) is one representative of a new class of compounds with antiinflammatory, analgesic and antipyretic properties as evidenced by its activity in a variety of tests in rats, mice and guinea-pigs.
2. In tests of short duration the potency of fenclozic acid is similar to that of phenylbutazone.
3. In tests of longer duration fenclozic acid is more potent than phenylbutazone.
4. The activity of fenclozic acid is not mediated by stimulation of the adrenals and the compound is devoid of corticosteroid-like activity.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BURNS J. J., ROSE R. K., CHENKIN T., GOLDMAN A., SCHULERT A., BRODIE B. B. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther. 1953 Nov;109(3):346–357. [PubMed] [Google Scholar]
- Davies G. E. Immunosuppressive activity of 3-acetyl-5-(4-fluorobenzylidene)-4-hydroxy-2-oxo-2:5-dihydrothiophen (I.C.I. 47,776). Immunology. 1968 Mar;14(3):393–399. [PMC free article] [PubMed] [Google Scholar]
- Foulkes D. M. Metabolism of thiazole acetic acid derivatives and the NIH shift. Nature. 1969 Feb 8;221(5180):582–582. doi: 10.1038/221582a0. [DOI] [PubMed] [Google Scholar]
- Franklin T. J., Newbould B. B., O'Mant D. M., Scott A. I., Stacey G. J., Davies G. E. A new type of cytotoxic immunosuppressive agent: 3-acetyl-5-(4-fluorbenzylidiene)4-hydroxy-2-oxo-2:5-dihydrothiophen. Nature. 1966 May 7;210(5036):638–639. doi: 10.1038/210638a0. [DOI] [PubMed] [Google Scholar]
- Hepworth W., Newbould B. B., Platt D. S., Stacey G. J. 2-(4-chlorophenyl)thiazol-4-ylacetic acid('Myalex'): a new compound with anti-inflammatory,, analgesic and antipyretic activity. Nature. 1969 Feb 8;221(5180):582–583. doi: 10.1038/221582b0. [DOI] [PubMed] [Google Scholar]
- NEWBOULD B. B. CHEMOTHERAPY OF ARTHRITIS INDUCED IN RATS BY MYCOBACTERIAL ADJUVANT. Br J Pharmacol Chemother. 1963 Aug;21:127–136. doi: 10.1111/j.1476-5381.1963.tb01508.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NEWBOULD B. B. SUPPRESSION OF ADJUVANT-INDUCED ARTHRITIS IN RATS WITH 2-BUTOXYCARBONYLMETHYLENE-4-OXOTHIAZOLIDINE. Br J Pharmacol Chemother. 1965 Jun;24:632–640. doi: 10.1111/j.1476-5381.1965.tb01619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O'Brien W. M. Indomethacin: a survey of clinical trials. Clin Pharmacol Ther. 1968 Jan-Feb;9(1):94–107. doi: 10.1002/cpt19689194. [DOI] [PubMed] [Google Scholar]
- PEARSON C. M. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med. 1956 Jan;91(1):95–101. doi: 10.3181/00379727-91-22179. [DOI] [PubMed] [Google Scholar]
- WHITTLE B. A. THE USE OF CHANGES IN CAPILLARY PERMEABILITY IN MICE TO DISTINGUISH BETWEEN NARCOTIC AND NONNARCOTIC ALALGESICS. Br J Pharmacol Chemother. 1964 Apr;22:246–253. doi: 10.1111/j.1476-5381.1964.tb02030.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WINDER C. V., WAX J., BURR V., BEEN M., ROSIERE C. E. A study of pharmacological influences on ultraviolet erythema in guinea pigs. Arch Int Pharmacodyn Ther. 1958 Sep 1;116(3-4):261–293. [PubMed] [Google Scholar]
- WINTER C. A., RISLEY E. A., NUSS G. W. ANTI-INFLAMMATORY AND ANTIPYRETIC ACTIVITIES OF INDOMETHACIN, 1-(P-CHLOROBENZOYL)-5-METHOXY-2-METHYLINDOLE-3-ACETIC ACID. J Pharmacol Exp Ther. 1963 Sep;141:369–376. [PubMed] [Google Scholar]
- WINTER C. A., RISLEY E. A., NUSS G. W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med. 1962 Dec;111:544–547. doi: 10.3181/00379727-111-27849. [DOI] [PubMed] [Google Scholar]